首页> 外文期刊>Science >Mutational analysis of the tyrosine phosphatome in colorectal cancers
【24h】

Mutational analysis of the tyrosine phosphatome in colorectal cancers

机译:大肠癌中酪氨酸磷酸酯的突变分析

获取原文
获取原文并翻译 | 示例
       

摘要

Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis. A mutational analysis of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers and a smaller fraction of lung, breast, and gastric cancers. Fifteen mutations were nonsense, frameshift, or splice-site alterations predicted to result in truncated proteins lacking phosphatase activity. Five missense mutations in the most commonly altered PTP ( PTPRT) were biochemically examined and found to reduce phosphatase activity. Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth. These observations suggest that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.
机译:酪氨酸磷酸化受蛋白质酪氨酸磷酸酶(PTP)和激酶(PTK)的调节,在肿瘤发生的信号通路中很重要。对人类癌症中酪氨酸磷酸酶基因超家族的突变分析,确定了六个PTP(PTPRF,PTPRG,PTPRT,PTPN3,PTPN13,PTPN14)中的83个体细胞突变,影响了26%的结直肠癌以及较小比例的肺癌,乳腺癌和胃癌癌症。十五个突变是无意义的,移码的或剪接位点的改变,预计会导致截短的蛋白缺乏磷酸酶活性。生化检查了最常改变的PTP(PTPRT)中的五个错义突变,发现它们降低了磷酸酶的活性。在人类癌细胞中表达野生型而非突变型PTPRT可以抑制细胞生长。这些观察结果表明突变的酪氨酸磷酸酶是肿瘤抑制基因,调节可能适合治疗干预的细胞途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号